MICROBOT MEDICAL INC. (NASDAQ:MBOT) Files An 8-K Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year

MICROBOT MEDICAL INC. (NASDAQ:MBOT) Files An 8-K Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.

Story continues below

On December 12, 2018, Microbot Medical Inc. (the “Company”) filed a Certificate of Elimination with the Secretary of State of the State of Delaware with respect to its Preferred Stock which, effective upon filing, eliminated from the Company’s Certificate of Incorporation, as amended, all matters set forth in the Certificate of Designation of Preferences, Rights and Limitations for the Preferred Stock filed with the Secretary of State of the State of Delaware on December 16, 2016, and in the Certificate of Designation of Preferences, Rights and Limitations for the Preferred Stock filed with the Secretary of State of the State of Delaware on May 10, 2017.

A copy of the Certificate of Elimination is attached as Exhibit 3.1 to this Current Report on Form 8-K and is incorporated by reference herein.

Item 9.01 Financial Statements and Exhibits.

Exhibit Description
3.1 Certificate of Elimination

Microbot Medical Inc. Exhibit
EX-3.1 2 ex3-1.htm   CERTIFICATE OF ELIMINATION   OF THE   SERIES A CONVERTIBLE PREFERRED STOCK   OF MICROBOT MEDICAL INC.   (Pursuant to Section 151(g) of the General Corporation Law of the State of Delaware)   The undersigned Chief Executive Officer of Microbot Medical Inc.,…
To view the full exhibit click here

About MICROBOT MEDICAL INC. (NASDAQ:MBOT)

Microbot Medical Inc., formerly StemCells, Inc., is a medical device company. The Company specializes in the researching, designing, developing and commercializing transformational micro-robotic medical technologies leveraging the artificial and natural lumens within the human body. It is engaged in developing its two product candidates: the Self Cleaning Shunt (SCS) for the treatment of hydrocephalus and normal pressure hydrocephalus (NPH), and TipCAT, a self-propelling, semi-disposable endoscope that the Company is developing for use in colonoscopy procedures. Its ViRob technology is an autonomous crawling micro-robot, which can be controlled remotely or within the body. The Microbot SCS device is a robotic system designed as the ventricular catheter portion of a cerebrospinal fluid (CSF) shunt system. The Company’s TipCAT is an endoscope that provides see and treat capabilities within tubular lumens in the human body, such as the colon, blood vessels and the urinary tract.

An ad to help with our costs